Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Publishing timestamp: 2024-04-04 13:09:08
Summary
A diabetes drug called lixisenatide, made by Sanofi, showed potential to help patients with Parkinson's disease by slowing the progression of motor disability in a small mid-stage trial. Larger studies are needed to fully determine efficacy and safety, but the results are seen as an encouraging step forward in the effort to tackle Parkinson's disease.
Sentiment: MIXED
Tickers: NOVO.B-DK, LLY, SNY, SAN-FR, NVO,
Keywords: novo nordisk a/s, sanofi sa, health care industry, pharmaceuticals, science, biotech and pharmaceuticals, eli lilly and co, business, business news, biotechnology,